Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open‐label, phase III, non‐inferiority study

@inproceedings{Araki2015EfficacyAS,
  title={Efficacy and safety of once‐weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once‐daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open‐label, phase III, non‐inferiority study},
  author={Eiichi Araki and Nobuya Inagaki and Yukio Tanizawa and Tomonori Oura and Masakazu Takeuchi and Takeshi Imaoka},
  booktitle={Diabetes, obesity & metabolism},
  year={2015}
}
AIMS To evaluate 0.75 mg of dulaglutide, a once-weekly glucagon-like peptide-1 receptor agonist, compared with once-daily insulin glargine for glycaemic control in Japanese patients with type 2 diabetes (T2D). METHODS In this phase III, randomized, open-label, parallel-group, 26-week study, 361 patients with inadequately controlled T2D receiving sulphonylureas and/or biguanides, aged ≥20 years, with glycated haemoglobin (HbA1c) levels 7.0-10.0% (53-86 mmol/mol), inclusive, were randomized (1… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
23 Citations
42 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Trulicity [Summary of product characteristics

  • Eli Lilly, Company, Houten
  • Available from URL: http://www.ema.europa.eu/ema…
  • 2014
Highly Influential
14 Excerpts

Bydureon [Japan package insert

  • AstraZeneca K.K, Osaka
  • Volume 17 No
  • 2015
1 Excerpt

Byetta [Japan package insert

  • AstraZeneca K.K, Osaka
  • Available from URL: http://www.info.pmda.go.jp…
  • 2015
1 Excerpt

Efficacy and safety of once-weekly dulaglutide versus insulin glargine in combination with metformin and glimepiride in type 2 diabetes patients

  • F Giorgino, M Benroubi, JH Sun, AG Zimmermann, V. Pechtner
  • Diabetes
  • 2014

Similar Papers

Loading similar papers…